Targeting extracellular matrix stiffness to attenuate disease: from molecular mechanisms to clinical trials

Tissue Cells Feel and Respond to the Stiffness of Their Substrate

Discher, D. E., Janmey, P., & Wang, Y.-L. (2005) · Science · doi:10.1126/science.1116995 · Cited by 6,382 · see citing works

Role of YAP/TAZ in mechanotransduction

Dupont, S., Morsut, L., Aragona, M., Enzo, E., Giulitti, S., Cordenonsi, M., Zanconato, F., Le Digabel, J., Forcato, M., Bicciato, S., et al. (2011) · Nature · doi:10.1038/nature10137 · Cited by 5,979 · see citing works

The Nuclear Factor NF- B Pathway in InflammationPreprint

Lawrence, T. (2009) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a001651 · Cited by 4,926 · see citing works

Remodelling the extracellular matrix in development and disease

Bonnans, C., Chou, J., & Werb, Z. (2014) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3904 · Cited by 4,367 · see citing works

The biology and function of fibroblasts in cancer

Kalluri, R. (2016) · Nature Reviews Cancer · doi:10.1038/nrc.2016.73 · Cited by 4,366 · see citing works

The extracellular matrix at a glance

Frantz, C., Stewart, K. M., & Weaver, V. M. (2010) · Journal of Cell Science · doi:10.1242/jcs.023820 · Cited by 4,334 · see citing works

Tensional homeostasis and the malignant phenotype

Paszek, M. J., Zahir, N., Johnson, K. R., Lakins, J. N., Rozenberg, G. I., Gefen, A., Reinhart-King, C. A., Margulies, S. S., Dembo, M., Boettiger, D., et al. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.08.010 · Cited by 3,941 · see citing works

Depletion of Carcinoma-Associated Fibroblasts and Fibrosis Induces Immunosuppression and Accelerates Pancreas Cancer with Reduced Survival

Özdemir, B. C., Pentcheva-Hoang, T., Carstens, J. L., Zheng, X., Wu, C.-C., Simpson, T. R., Laklai, H., Sugimoto, H., Kahlert, C., Novitskiy, S. V., et al. (2014) · Cancer Cell · doi:10.1016/j.ccr.2014.04.005 · Cited by 2,681 · see citing works

Effects of substrate stiffness on cell morphology, cytoskeletal structure, and adhesion

Yeung, T., Georges, P. C., Flanagan, L. A., Marg, B., Ortiz, M., Funaki, M., Zahir, N., Ming, W., Weaver, V., & Janmey, P. A. (2005) · Cell Motility and the Cytoskeleton · doi:10.1002/cm.20041 · Cited by 2,325 · see citing works

Mechanotransduction and extracellular matrix homeostasis

Humphrey, J. D., Dufresne, E. R., & Schwartz, M. A. (2014) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3896 · Cited by 2,187 · see citing works

The Myofibroblast

Hinz, B., Phan, S. H., Thannickal, V. J., Galli, A., Bochaton-Piallat, M.-L., & Gabbiani, G. (2007) · The American Journal of Pathology · doi:10.2353/ajpath.2007.070112 · Cited by 2,068 · see citing works

The extracellular matrix modulates the hallmarks of cancer

Pickup, M. W., Mouw, J. K., & Weaver, V. M. (2014) · EMBO Reports · doi:10.15252/embr.201439246 · Cited by 2,014 · see citing works

Nuclear Lamin-A Scales with Tissue Stiffness and Enhances Matrix-Directed Differentiation

Swift, J., Ivanovska, I. L., Buxboim, A., Harada, T., Dingal, P. C. D. P., Pinter, J., Pajerowski, J. D., Spinler, K. R., Shin, J., Tewari, M., et al. (2013) · Science · doi:10.1126/science.1240104 · Cited by 1,998 · see citing works

Cell surface-localized matrix metalloproteinase-9 proteolytically activates TGF-beta and promotes tumor invasion and angiogenesis.

Yu, Q., & Stamenkovic, I. (2000) · PubMed · Cited by 1,952 · see citing works

Mechanotransduction at a distance: mechanically coupling the extracellular matrix with the nucleus

Wang, N., Tytell, J. D., & Ingber, D. E. (2008) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2594 · Cited by 1,768 · see citing works

Cell surface-localized matrix metalloproteinase-9 proteolytically activates TGF-β and promotes tumor invasion and angiogenesis

Yu, Q., & Stamenkovic, I. (2000) · Genes & Development · doi:10.1101/gad.14.2.163 · Cited by 1,754 · see citing works

A Mechanical Checkpoint Controls Multicellular Growth through YAP/TAZ Regulation by Actin-Processing Factors

Aragona, M., Panciera, T., Manfrin, A., Giulitti, S., Michielin, F., Elvassore, N., Dupont, S., & Piccolo, S. (2013) · Cell · doi:10.1016/j.cell.2013.07.042 · Cited by 1,651 · see citing works

Pegaptanib, a targeted anti-VEGF aptamer for ocular vascular disease

Ng, E. W. M., Shima, D. T., Calias, P., Cunningham, E. T., Guyer, D. R., & Adamis, A. P. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd1955 · Cited by 1,591 · see citing works

Integrin signalling during tumour progression

Guo, W., & Giancotti, F. G. (2004) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1490 · Cited by 1,473 · see citing works

Targeting the TGFβ signalling pathway in disease

Akhurst, R. J., & Hata, A. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3810 · Cited by 1,466 · see citing works

Genetic and pharmacological disruption of the TEAD–YAP complex suppresses the oncogenic activity of YAP

Liu-Chittenden, Y., Huang, B., Shim, J. S., Chen, Q., Lee, S.-J., Anders, R. A., Liu, J. O., & Pan, D. (2012) · Genes & Development · doi:10.1101/gad.192856.112 · Cited by 1,452 · see citing works

FAK in cancer: mechanistic findings and clinical applications

Sulzmaier, F. J., Jean, C., & Schlaepfer, D. D. (2014) · Nature Reviews Cancer · doi:10.1038/nrc3792 · Cited by 1,381 · see citing works

Myofibroblast contraction activates latent TGF-β1 from the extracellular matrix

Wipff, P.-J., Rifkin, D. B., Meister, J.-J., & Hinz, B. (2007) · The Journal of Cell Biology · doi:10.1083/jcb.200704042 · Cited by 1,346 · see citing works

NF-κB in the liver—linking injury, fibrosis and hepatocellular carcinoma

Luedde, T., & Schwabe, R. F. (2011) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2010.213 · Cited by 1,345 · see citing works

Transforming growth factor beta modulates the expression of collagenase and metalloproteinase inhibitor.

Edwards, D. R., Murphy, G., Reynolds, J. J., Whitham, S. E., Docherty, A. J., Angel, P., & Heath, J. K. (1987) · The EMBO Journal · doi:10.1002/j.1460-2075.1987.tb02449.x · Cited by 1,221 · see citing works

TGF-β signaling in fibrosis

Biernacka, A., Dobaczewski, M. P., & Frangogiannis, N. G. (2011) · Growth Factors · doi:10.3109/08977194.2011.595714 · Cited by 1,175 · see citing works

Targeting RAS–ERK signalling in cancer: promises and challenges

Samatar, A. A., & Poulikakos, P. I. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4281 · Cited by 1,163 · see citing works

Aortic Stiffness, Blood Pressure Progression, and Incident Hypertension

Kaess, B. M., Rong, J., Larson, M. G., Hamburg, N. M., Vita, J. A., Levy, D. A., Benjamin, E. J., Vasan, R. S., & Mitchell, G. F. (2012) · JAMA · doi:10.1001/2012.jama.10503 · Cited by 1,086 · see citing works

Is NF-κB a good target for cancer therapy? Hopes and pitfalls

Baud, V., & Karin, M. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2781 · Cited by 1,059 · see citing works

Cilengitide combined with standard treatment for patients with newly diagnosed glioblastoma with methylated MGMT promoter (CENTRIC EORTC 26071-22072 study): a multicentre, randomised, open-label, phase 3 trial

Stupp, R., Hegi, M. E., Gorlia, T., Erridge, S. C., Perry, J., Hong, Y.-K., Aldape, K. D., Lhermitte, B., Pietsch, T., Grujicic, D., et al. (2014) · The Lancet Oncology · doi:10.1016/s1470-2045(14)70379-1 · Cited by 1,052 · see citing works

The MAPK cascades: Signaling components, nuclear roles and mechanisms of nuclear translocation

Plotnikov, A. N., Zehorai, E., Procaccia, S., & Seger, R. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2010.12.012 · Cited by 990 · see citing works

Dynamic molecular processes mediate cellular mechanotransduction

Hoffman, B. D., Grashoff, C., & Schwartz, M. A. (2011) · Nature · doi:10.1038/nature10316 · Cited by 956 · see citing works

Matrix stiffness drives epithelial–mesenchymal transition and tumour metastasis through a TWIST1–G3BP2 mechanotransduction pathway

Wei, S. C., Fattet, L., Tsai, J. H., Guo, Y., Pai, V. H., Majeski, H. E., Chen, A. C., Sah, R. L., Taylor, S. S., Engler, A. J., et al. (2015) · Nature Cell Biology · doi:10.1038/ncb3157 · Cited by 934 · see citing works

Regulating Rho GTPases and their regulators

Hodge, R. G., & Ridley, A. J. (2016) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm.2016.67 · Cited by 903 · see citing works

Connective-tissue growth factor (CTGF) modulates cell signalling by BMP and TGF-β

Abreu, J. G., Ketpura, N. I., Reversade, B., & Robertis, E. M. D. (2002) · Nature Cell Biology · doi:10.1038/ncb826 · Cited by 901 · see citing works

Mechanosignaling through YAP and TAZ drives fibroblast activation and fibrosis

Liu, F., Lagares, D., Choi, K. M., Stopfer, L., Marinković, A., Vrbanac, V., Probst, C. K., Hiemer, S. E., Sisson, T. H., Horowitz, J. C., et al. (2015) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00300.2014 · Cited by 874 · see citing works

Is there new hope for therapeutic matrix metalloproteinase inhibition?

Vandenbroucke, R. E., & Libert, C. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4390 · Cited by 840 · see citing works

Metabolic control of YAP and TAZ by the mevalonate pathway

Sorrentino, G., Ruggeri, N., Specchia, V., Cordenonsi, M., Mano, M., Dupont, S., Manfrin, A., Ingallina, E., Sommaggio, R., Piazza, S., et al. (2014) · Nature Cell Biology · doi:10.1038/ncb2936 · Cited by 779 · see citing works

The myofibroblast matrix: implications for tissue repair and fibrosis

Klingberg, F., Hinz, B., & White, E. S. (2013) · The Journal of Pathology · doi:10.1002/path.4104 · Cited by 776 · see citing works

Integrins and cancer: regulators of cancer stemness, metastasis, and drug resistance

Seguin, L., Desgrosellier, J. S., Weis, S. M., & Cheresh, D. A. (2015) · Trends in Cell Biology · doi:10.1016/j.tcb.2014.12.006 · Cited by 685 · see citing works

Matrix density-induced mechanoregulation of breast cell phenotype, signaling and gene expression through a FAK–ERK linkage

Provenzano, P. P., Inman, D. R., Eliceiri, K. W., & Keely, P. J. (2009) · Oncogene · doi:10.1038/onc.2009.299 · Cited by 667 · see citing works

Tissue Stiffness Dictates Development, Homeostasis, and Disease Progression

Handorf, A. M., Zhou, Y., Halanski, M. A., & Li, W. (2015) · Organogenesis · doi:10.1080/15476278.2015.1019687 · Cited by 647 · see citing works

Rac and Rho GTPases in cancer cell motility control

Parri, M., & Chiarugi, P. (2010) · Cell Communication and Signaling · doi:10.1186/1478-811x-8-23 · Cited by 641 · see citing works

A Peptide Mimicking VGLL4 Function Acts as a YAP Antagonist Therapy against Gastric Cancer

Jiao, S., Wang, H., Shi, Z., Dong, A., Zhang, W., Song, X., He, F., Wang, Y., Zhang, Z., Wang, W., et al. (2014) · Cancer Cell · doi:10.1016/j.ccr.2014.01.010 · Cited by 605 · see citing works

Evolving therapies for liver fibrosis

Schuppan, D., & Kim, Y. O. (2013) · Journal of Clinical Investigation · doi:10.1172/jci66028 · Cited by 596 · see citing works

Pleiotropic effects of statin therapy: molecular mechanisms and clinical results

Wang, C., Liu, P., & Liao, J. K. (2008) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2007.11.004 · Cited by 593 · see citing works

The rationale for targeting the LOX family in cancer

Barker, H. E., Cox, T. R., & Erler, J. T. (2012) · Nature reviews. Cancer · doi:10.1038/nrc3319 · Cited by 592 · see citing works

Increased stiffness of the rat liver precedes matrix deposition: implications for fibrosis

Georges, P. C., Hui, J.-J., Gombos, Z., McCormick, M. E., Wang, A. Y., Uemura, M., Mick, R., Janmey, P. A., Furth, E. E., & Wells, R. G. (2007) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00032.2007 · Cited by 577 · see citing works

CTGF is a central mediator of tissue remodeling and fibrosis and its inhibition can reverse the process of fibrosis

Lipson, K. E., Wong, C., Teng, Y., & Spong, S. M. (2012) · Fibrogenesis & Tissue Repair · doi:10.1186/1755-1536-5-s1-s24 · Cited by 576 · see citing works

Recent trends in cardiovascular mortality in the United States and public health goals.

Sidney, S., Quesenberry, C. P., Jaffe, M. G., Sorel, M., Nguyen-Huynh, M. N., Kushi, L. H., Go, A. S., & Rana, J. S. (2016) · JAMA Cardiology · doi:10.1001/jamacardio.2016.1326 · Cited by 569 · see citing works

Cell-ECM traction force modulates endogenous tension at cell–cell contacts

Maruthamuthu, V., Sabass, B., Schwarz, U. S., & Gardel, M. L. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1011123108 · Cited by 520 · see citing works

Phase I study of GC1008 (fresolimumab): a human anti‐transforming growth factor‐beta (TGFβ) monoclonal antibody in patients with advanced malignant melanoma or renal cell carcinoma

Morris, J. C., Tan, A. R., Olencki, T. E., Shapiro, G. I., Dezube, B. J., Reiss, M., Hsu, F. J., Berzofsky, J. A., & Lawrence, D. P. (2014) · PLoS ONE · doi:10.1371/journal.pone.0090353 · Cited by 487 · see citing works

The Compliance of Collagen Gels Regulates Transforming Growth Factor-β Induction of α-Smooth Muscle Actin in Fibroblasts

Arora, P. D., Narani, N., & McCulloch, C. A. (1999) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)65334-5 · Cited by 465 · see citing works

Gene Expression Profiles Distinguish Idiopathic Pulmonary Fibrosis from Hypersensitivity Pneumonitis

Selman, M., Pardo, A., Barrera, L., Estrada, A., Watson, S. R., Wilson, K., Aziz, N. A., Kaminski, N., & Zlotnik, A. (2005) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200504-644oc · Cited by 455 · see citing works

3D collagen alignment limits protrusions to enhance breast cancer cell persistence

Riching, K. M., Cox, B. L., Salick, M. R., Pehlke, C., Riching, A. S., Ponik, S. M., Bass, B. R., Crone, W. C., Jiang, Y., Weaver, A. M., et al. (2014) · Biophysical Journal · doi:10.1016/j.bpj.2014.10.035 · Cited by 446 · see citing works

Age-related vascular stiffening: causes and consequences

Kohn, J. C., Lampi, M. C., & Reinhart-King, C. A. (2015) · Frontiers in Genetics · doi:10.3389/fgene.2015.00112 · Cited by 440 · see citing works

FAK signaling in human cancer as a target for therapeutics

Lee, B. Y., Timpson, P., Horvath, L. G., & Daly, R. J. (2014) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2014.10.001 · Cited by 431 · see citing works

β1- and αv-class integrins cooperate to regulate myosin II during rigidity sensing of fibronectin-based microenvironments

Schiller, H. B., Hermann, M.-R., Polleux, J., Vignaud, T., Zanivan, S. R., Friedel, C. C., Sun, Z., Raducanu, A., Gottschalk, K., Théry, M., et al. (2013) · Nature Cell Biology · doi:10.1038/ncb2747 · Cited by 430 · see citing works

Matrix stiffening promotes a tumor vasculature phenotype

Bordeleau, F., Mason, B. N., Lollis, E. M., Mazzola, M. C., Zanotelli, M. R., Somasegar, S., Califano, J. P., Montague, C. R., LaValley, D. J., Huynh, J., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1613855114 · Cited by 419 · see citing works

The Hippo pathway effector YAP controls mouse hepatic stellate cell activation

Mannaerts, I., Leite, S. B., Verhulst, S., Claerhout, S., Eysackers, N., Thoen, L. F. R., Hoorens, A., Reynaert, H., Halder, G., & van Grunsven, L. A. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2015.04.011 · Cited by 410 · see citing works

Age-Related Intimal Stiffening Enhances Endothelial Permeability and Leukocyte Transmigration

Huynh, J., Nishimura, N., Rana, K., Peloquin, J. M., Califano, J. P., Montague, C. R., King, M. R., Schaffer, C. B., & Reinhart‐King, C. A. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3002761 · Cited by 403 · see citing works

Cellular Traction Stresses Increase with Increasing Metastatic Potential

Kraning-Rush, C. M., Califano, J. P., & Reinhart‐King, C. A. (2012) · PLoS ONE · doi:10.1371/journal.pone.0032572 · Cited by 393 · see citing works

Does This Patient Have Breast Cancer?

Barton, M. B., Harris, R., & Fletcher, S. W. (1999) · JAMA · doi:10.1001/jama.282.13.1270 · Cited by 371 · see citing works

The Rho GEFs LARG and GEF-H1 regulate the mechanical response to force on integrins

Guilluy, C., Swaminathan, V., García‐Mata, R., O’Brien, E. T., Superfine, R., & Burridge, K. (2011) · Nature Cell Biology · doi:10.1038/ncb2254 · Cited by 369 · see citing works

The Challenge of Drugging Undruggable Targets in Cancer: Lessons Learned from Targeting BCL-2 Family Members

Verdine, G. L., & Walensky, L. D. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-2184 · Cited by 362 · see citing works

Restriction of Dietary Glycotoxins Reduces Excessive Advanced Glycation End Products in Renal Failure Patients

Uribarri, J., Peppa, Μ., Cai, W., Goldberg, T., Lu, M. M., He, C., & Vlassara, H. (2003) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000051593.41395.b9 · Cited by 331 · see citing works

Arterial Stiffening Precedes Systolic Hypertension in Diet-Induced Obesity

Weisbrod, R. M., Shiang, T., Al Sayah, L., Fry, J. L., Bajpai, S., Reinhart-King, C. A., Lob, H. E., Santhanam, L., Mitchell, G., Cohen, R. A., et al. (2013) · Hypertension · doi:10.1161/hypertensionaha.113.01744 · Cited by 317 · see citing works

The α _v β ₁ integrin plays a critical in vivo role in tissue fibrosis

Reed, N. I., Jo, H., Chen, C., Tsujino, K., Arnold, T. D., DeGrado, W. F., & Sheppard, D. (2015) · Science Translational Medicine · doi:10.1126/scitranslmed.aaa5094 · Cited by 311 · see citing works

Targeting Nuclear Factor-Kappa B to Overcome Resistance to Chemotherapy

Godwin, P., Baird, A., Heavey, S., Barr, M. P., O'Byrne, K. J., & Gately, K. A. (2013) · Frontiers in Oncology · doi:10.3389/fonc.2013.00120 · Cited by 302 · see citing works

MMPs as therapeutic targets—Still a viable option?

Fingleton, B. (2007) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2007.06.006 · Cited by 280 · see citing works

Efficacy of simtuzumab versus placebo in patients with idiopathic pulmonary fibrosis: a randomised, double-blind, controlled, phase 2 trial

Raghu, G., Brown, K. K., Collard, H. R., Cottin, V., Gibson, K. F., Kaner, R. J., Lederer, D. J., Martinez, F. J., Noble, P. W., Song, J. W., et al. (2017) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(16)30421-0 · Cited by 278 · see citing works

Masters and servants of the force: The role of matrix adhesions in myofibroblast force perception and transmission

Hinz, B. (2005) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2005.09.004 · Cited by 272 · see citing works

Emerging roles of ADAM and ADAMTS metalloproteinases in cancer

Rocks, N., Paulissen, G., Hour, M. E., Quesada, F., Crahay, C., Gueders, M. M., Foidart, J. M., Noël, A., & Cataldo, D. D. (2007) · Biochimie · doi:10.1016/j.biochi.2007.08.008 · Cited by 266 · see citing works

Transient tissue priming via ROCK inhibition uncouples pancreatic cancer progression, sensitivity to chemotherapy, and metastasis

Vennin, C., Chin, V. T., Warren, S. C., Lucas, M. C., Herrmann, D., Magenau, A., Mélénec, P., Walters, S. N., del Monte‐Nieto, G., Conway, J. R. W., et al. (2017) · Science Translational Medicine · doi:10.1126/scitranslmed.aai8504 · Cited by 264 · see citing works

Cross‐Linking of the Extracellular Matrix by the Maillard Reaction in Aging and Diabetes: An Update on “a Puzzle Nearing Resolution”

Monnier, V. M., Mustata, G. T., Biemel, K. M., Reihl, O., LEDERER, M. O., ZHENYU, D., & Sell, D. R. (2005) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1333.061 · Cited by 245 · see citing works

Influencing the Tumor Microenvironment: A Phase II Study of Copper Depletion Using Tetrathiomolybdate in Patients with Breast Cancer at High Risk for Recurrence and in Preclinical Models of Lung Metastases

Chan, N., Willis, A. D., Kornhauser, N., Ward, M. M., Lee, S. B., Nackos, E., Seo, B. R., Chuang, E., Cigler, T., Moore, A. L., et al. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-16-1326 · Cited by 233 · see citing works

Rational Design of Small Molecule Inhibitors Targeting RhoA Subfamily Rho GTPases

Shang, X., Marchioni, F., Sipes, N. S., Evelyn, C. R., Jerabek‐Willemsen, M., Duhr, S., Seibel, W. L., Wortman, M. D., & Zheng, Y. (2012) · Chemistry & Biology · doi:10.1016/j.chembiol.2012.05.009 · Cited by 226 · see citing works

The NH2-terminal peptide of α–smooth muscle actin inhibits force generation by the myofibroblast in vitro and in vivo

Hinz, B., Gabbiani, G., & Chaponnier, C. (2002) · The Journal of Cell Biology · doi:10.1083/jcb.200201049 · Cited by 226 · see citing works

Lysyl oxidase activity contributes to collagen stabilization during liver fibrosis progression and limits spontaneous fibrosis reversal in mice

Liu, S. B., Ikenaga, N., Peng, Z., Sverdlov, D. Y., Greenstein, A., Smith, V., Schuppan, D., & Popov, Y. (2016) · The FASEB Journal · doi:10.1096/fj.14-268425 · Cited by 224 · see citing works

Engagement of αvβ3 Integrin Regulates Proliferation and Apoptosis of Hepatic Stellate Cells

Zhou, X., Murphy, F. R., Gehdu, N., Zhang, J., Iredale, J. P., & Benyon, R. C. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m311668200 · Cited by 219 · see citing works

CD36 Repression Activates a Multicellular Stromal Program Shared by High Mammographic Density and Tumor Tissues

DeFilippis, R. A., Chang, H., Dumont, N., Rabban, J. T., Chen, Y.-Y., Fontenay, G. V., Berman, H. K., Gauthier, M. L., Zhao, J., Hu, D., et al. (2012) · Cancer Discovery · doi:10.1158/2159-8290.cd-12-0107 · Cited by 212 · see citing works

Integrin-mediated regulation of TGFβ in fibrosis

Henderson, N. C., & Sheppard, D. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2012.10.005 · Cited by 209 · see citing works

Phase 1 Study of Anti-CTGF Monoclonal Antibody in Patients with Diabetes and Microalbuminuria

Adler, S. G., Schwartz, S. L., Williams, M. E., Arauz-Pacheco, C., Bolton, W. K., Lee, T. T., Li, D., Neff, T. B., Urquilla, P. R., & Sewell, K. L. (2010) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.09321209 · Cited by 205 · see citing works

Novel Rho/MRTF/SRF Inhibitors Block Matrix-stiffness and TGF-β–Induced Fibrogenesis in Human Colonic Myofibroblasts

Johnson, L. A., Rodansky, E. S., Haak, A. J., Larsen, S. D., Neubig, R. R., & Higgins, P. (2013) · Inflammatory Bowel Diseases · doi:10.1097/01.mib.0000437615.98881.31 · Cited by 198 · see citing works

A Phase II Randomized, Double-Blind, Placebo-Controlled Study of Simtuzumab or Placebo in Combination with Gemcitabine for the First-Line Treatment of Pancreatic Adenocarcinoma

Benson, A. B., Wainberg, Z. A., Hecht, J. R., Михайлович, В. Д., Dong, H., Bendell, J. C., & Kudrik, F. J. (2017) · The Oncologist · doi:10.1634/theoncologist.2017-0024 · Cited by 198 · see citing works

Targeting FAK in human cancer: from finding to first clinical trials

Golubovskaya, V. (2014) · Frontiers in bioscience · doi:10.2741/4236 · Cited by 197 · see citing works

Cellular mechanosensing: Getting to the nucleus of it all

Fedorchak, G. R., Kaminski, A., & Lammerding, J. (2014) · Progress in Biophysics and Molecular Biology · doi:10.1016/j.pbiomolbio.2014.06.009 · Cited by 191 · see citing works

Cardiovascular Protection by ApoE and ApoE-HDL Linked to Suppression of ECM Gene Expression and Arterial Stiffening

Kothapalli, D., Liu, S., Bae, Y., Monslow, J., Xu, T., Hawthorne, E. A., Byfield, F. J., Castagnino, P. A., Rao, S. J., Rader, D. J., et al. (2012) · Cell Reports · doi:10.1016/j.celrep.2012.09.018 · Cited by 186 · see citing works

Drug targeting to myofibroblasts: Implications for fibrosis and cancer

Yazdani, S., Bansal, R., & Prakash, J. (2017) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2017.07.010 · Cited by 186 · see citing works

Transforming growth factor β regulates the levels of different fibronectin isoforms in normal human cultured fibroblasts

Balza, E., Borsi, L., Allemanni, G., & Zardi, L. (1988) · FEBS Letters · doi:10.1016/0014-5793(88)80580-5 · Cited by 181 · see citing works

FG-3019 anti-connective tissue growth factor monoclonal antibody: results of an open-label clinical trial in idiopathic pulmonary fibrosis

Raghu, G., Scholand, M. B., de Andrade, J. A., LANCASTER, L. H., Mageto, Y. N., Goldin, J. G., Brown, K. K., Flaherty, K. R., Wencel, M. L., Wanger, J. S., et al. (2016) · European Respiratory Journal · doi:10.1183/13993003.01030-2015 · Cited by 176 · see citing works

Ins and Outs of Kinase DFG Motifs

Treiber, D. K., & Shah, N. P. (2013) · Chemistry & Biology · doi:10.1016/j.chembiol.2013.06.001 · Cited by 174 · see citing works

Lysyl Oxidase, a Targetable Secreted Molecule Involved in Cancer Metastasis

Cox, T. R., Gartland, A., & Erler, J. T. (2016) · Cancer Research · doi:10.1158/0008-5472.can-15-2306 · Cited by 174 · see citing works

Fibrosis: recent advances in myofibroblast biology and new therapeutic perspectives

Hinz, B., & Gabbiani, G. (2010) · F1000 Biology Reports · doi:10.3410/b2-78 · Cited by 172 · see citing works

MicroRNAs in fibrosis: opportunities and challenges

O’Reilly, S. (2016) · Arthritis Research & Therapy · doi:10.1186/s13075-016-0929-x · Cited by 165 · see citing works

Increased expression of ADAM family members in human breast cancer and breast cancer cell lines

Lendeckel, U., Kohl, J., Arndt, M., Carl‐McGrath, S., Donat, H., & Röcken, C. (2004) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-004-0619-y · Cited by 163 · see citing works

ADAMTS proteases and cancer

Cal, S., & López-Otı́n, C. (2015) · Matrix Biology · doi:10.1016/j.matbio.2015.01.013 · Cited by 160 · see citing works

EDA‐containing cellular fibronectin induces fibroblast differentiation through binding to α 4 β 7 integrin receptor and MAPK/Erk 1/2‐dependent signaling

Kohan, M., Muro, A. F., White, E. S., & Berkman, N. (2010) · The FASEB Journal · doi:10.1096/fj.10-154435 · Cited by 160 · see citing works

ROS Signaling by NOX4 Drives Fibroblast-to-Myofibroblast Differentiation in the Diseased Prostatic Stroma

Sampson, N., Kozieł, R., Zenzmaier, C., Bubendorf, L., Plas, E., Jansen‐Dürr, P., & Berger, P. (2011) · Molecular Endocrinology · doi:10.1210/me.2010-0340 · Cited by 158 · see citing works

Small-molecule inhibitors targeting G-protein–coupled Rho guanine nucleotide exchange factors

Shang, X., Marchioni, F., Evelyn, C. R., Sipes, N. S., Zhou, X., Seibel, W. L., Wortman, M. D., & Zheng, Y. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1212324110 · Cited by 158 · see citing works

Rho-kinase inhibitors as therapeutics: from pan inhibition to isoform selectivity

Hahmann, C., & Schroeter, T. (2009) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-009-0189-x · Cited by 153 · see citing works

Rho Kinases in Cardiovascular Physiology and Pathophysiology

Shi, J., & Wei, L. (2013) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0b013e3182a3718f · Cited by 153 · see citing works

Matrix-metalloproteinases as targets for controlled delivery in cancer: An analysis of upregulation and expression

Isaacson, K. J., Jensen, M. M., Subrahmanyam, N. B., & Ghandehari, H. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.01.034 · Cited by 149 · see citing works

Decreased S -Nitrosylation of Tissue Transglutaminase Contributes to Age-Related Increases in Vascular Stiffness

Santhanam, L., Tuday, E. C., Webb, A. K., Dowzicky, P. M., Kim, J. H., Oh, Y. J., Sikka, G., Kuo, M. M., Halushka, M. K., Macgregor, A. M., et al. (2010) · Circulation Research · doi:10.1161/circresaha.109.215228 · Cited by 141 · see citing works

A Phase II, Randomized, Double-Blind, Placebo-Controlled Study of Simtuzumab in Combination with FOLFIRI for the Second-Line Treatment of Metastatic KRAS Mutant Colorectal Adenocarcinoma

Hecht, J. R., Benson, A. B., Михайлович, В. Д., Yang, Y., Bendell, J. C., & Verma, U. N. (2017) · The Oncologist · doi:10.1634/theoncologist.2016-0479 · Cited by 135 · see citing works

Life-long endurance running is associated with reduced glycation and mechanical stress in connective tissue

Couppé, C., Svensson, R. B., Grosset, J.-F., Kovanen, V., Nielsen, R. H., Olsen, M. R., Larsen, J. O., Praet, S., Skovgaard, D. C., Hansen, M., et al. (2014) · AGE · doi:10.1007/s11357-014-9665-9 · Cited by 131 · see citing works

Extracellular Matrix Stiffness Regulates Osteogenic Differentiation through MAPK Activation

Hwang, J.-H., Byun, M. R., Kim, A. R., Kim, K. M., Cho, H. J., Lee, Y. H., Kim, J.-W., Jeong, M. G., Hwang, E. S., & Hong, J. H. (2015) · PLoS ONE · doi:10.1371/journal.pone.0135519 · Cited by 130 · see citing works

Spotlight on ixazomib: potential in the treatment of multiple myeloma

Azab, A. K., Muz, B., Ghazarian, R., Ou, M., Luderer, M. J., & Kusdono, H. D. (2016) · Drug Design Development and Therapy · doi:10.2147/dddt.s93602 · Cited by 130 · see citing works

Overexpression of MMP9 in macrophages attenuates pulmonary fibrosis induced by bleomycin

Cabrera, S., Gaxiola, M., Arreola, J. L., Ramı́rez, R., Jara, P., D'Armiento, J. M., Richards, T. J., Selman, M., & Pardo, A. (2007) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2007.06.022 · Cited by 128 · see citing works

A COL11A1-correlated pan-cancer gene signature of activated fibroblasts for the prioritization of therapeutic targets

Jia, D., Liu, Z., Deng, N., Tan, T. Z., Huang, R. Y., Taylor‐Harding, B., Cheon, D., Lawrenson, K., Wiedemeyer, W. R., Walts, A. E., et al. (2016) · Cancer Letters · doi:10.1016/j.canlet.2016.09.001 · Cited by 128 · see citing works

Cellular micro-environments reveal defective mechanosensing responses and elevated YAP signaling in LMNA-mutated muscle precursors

Bertrand, A., Ziaei, S., Ehret, C., Duchemin, H., Mamchaoui, K., Bigot, A., Mayer, M., Quijano-Roy, S., Desguerre, I., Lainé, J., et al. (2014) · Journal of Cell Science · doi:10.1242/jcs.144907 · Cited by 127 · see citing works

Novel prospects of statins as therapeutic agents in cancer

Pisanti, S., Picardi, P., Ciaglia, E., D’Alessandro, A., & Bifulco, M. (2014) · Pharmacological Research · doi:10.1016/j.phrs.2014.06.013 · Cited by 126 · see citing works

Regulation of myofibroblast activities: Calcium pulls some strings behind the scene

Castella, L. F., Gabbiani, G., McCulloch, C. A., & Hinz, B. (2010) · Experimental Cell Research · doi:10.1016/j.yexcr.2010.04.033 · Cited by 123 · see citing works

Cell shape and the microenvironment regulate nuclear translocation of NF‐κB in breast epithelial and tumor cells

Sero, J., Sailem, H., Ardy, R. C., Almuttaqi, H., Zhang, T., & Bakal, C. (2015) · Molecular Systems Biology · doi:10.15252/msb.20145644 · Cited by 123 · see citing works

Micro‐RNA‐21 regulates TGF‐β‐induced myofibroblast differentiation by targeting PDCD4 in tumor‐stroma interaction

Yao, Q., Cao, S., Li, C., Mengesha, A., Kong, B., & Wei, M. (2010) · International Journal of Cancer · doi:10.1002/ijc.25506 · Cited by 120 · see citing works

An emerging treatment option for glaucoma: Rho kinase inhibitors

Chang, R. T., & Wang, S. K. (2014) · Clinical ophthalmology · doi:10.2147/opth.s41000 · Cited by 118 · see citing works

Nintedanib: First Global Approval

McCormack, P. L. (2014) · Drugs · doi:10.1007/s40265-014-0335-0 · Cited by 115 · see citing works

Rho kinase proteins--pleiotropic modulators of cell survival and apoptosis.

Street, C. A., & Bryan, B. A. (2011) · PubMed · Cited by 114 · see citing works

Cellular contractility and extracellular matrix stiffness regulate matrix metalloproteinase activity in pancreatic cancer cells

Haage, A., & Schneider, I. C. (2014) · The FASEB Journal · doi:10.1096/fj.13-245613 · Cited by 110 · see citing works

Simvastatin Inhibits Growth Factor Expression and Modulates Profibrogenic Markers in Lung Fibroblasts

Watts, K., Sampson, E. M., Schultz, G. S., & Spiteri, M. A. (2005) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2004-0127oc · Cited by 109 · see citing works

Crystal Structures of the FAK Kinase in Complex with TAE226 and Related Bis-Anilino Pyrimidine Inhibitors Reveal a Helical DFG Conformation

Lietha, D., & Eck, M. J. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003800 · Cited by 108 · see citing works

Combination therapies in oncology

Webster, R. M. (2016) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2016.3 · Cited by 106 · see citing works

A small molecule focal adhesion kinase (FAK) inhibitor, targeting Y397 site: 1-(2-hydroxyethyl) -3, 5, 7-triaza-1-azoniatricyclo [3.3.1.13,7]decane; bromide effectively inhibits FAK autophosphorylation activity and decreases cancer cell viability, clonogenicity and tumor growth in vivo

Golubovskaya, V., Figel, S. A., Ho, B. T., Johnson, C. P., Yemma, M., Huang, G., Zheng, M., Nyberg, C., Magis, A. T., Ostrov, D. A., et al. (2012) · Carcinogenesis · doi:10.1093/carcin/bgs120 · Cited by 103 · see citing works

Gradually softening hydrogels for modeling hepatic stellate cell behavior during fibrosis regression

Caliari, S. R., Perepelyuk, M., Soulas, E. M., Lee, G. Y., Wells, R. G., & Burdick, J. A. (2016) · Integrative Biology · doi:10.1039/c6ib00027d · Cited by 99 · see citing works

Tissue stiffness regulates serine/arginine-rich protein-mediated splicing of the extra domain B-fibronectin isoform in tumors

Bordeleau, F., Califano, J. P., Abril, Y. L. N., Mason, B. N., LaValley, D. J., Shin, S. J., Weiss, R. S., & Reinhart‐King, C. A. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1505421112 · Cited by 97 · see citing works

Long-term correction of bilirubin UDPglucuronyltransferase deficiency in rats by in utero lentiviral gene transfer

Seppen, J., van der Rijt, R., Looije, N., van Til, N. P., Lamers, W. H., & Elferink, R. P. J. O. (2003) · Molecular Therapy · doi:10.1016/s1525-0016(03)00234-x · Cited by 96 · see citing works

Alternative splicing as a biomarker and potential target for drug discovery

Le, K.-Q., Prabhakar, B. S., Hong, W.-J., & Li, L.-C. (2015) · Acta Pharmacologica Sinica · doi:10.1038/aps.2015.43 · Cited by 95 · see citing works

RPEL Proteins Are the Molecular Targets for CCG-1423, an Inhibitor of Rho Signaling

Hayashi, K., Watanabe, B., Nakagawa, Y., Minami, S., & Morita, T. (2014) · PLoS ONE · doi:10.1371/journal.pone.0089016 · Cited by 95 · see citing works

Binding of receptor for advanced glycation end products (RAGE) ligands is not sufficient to induce inflammatory signals: lack of activity of endotoxin-free albumin-derived advanced glycation end products

Mone, M. D., Koehne, C., Rediske, J. J., Hughes, T. E., & Valencia, J. (2004) · Diabetologia · doi:10.1007/s00125-004-1392-9 · Cited by 94 · see citing works

Protease profiling of liver fibrosis reveals the ADAM metallopeptidase with thrombospondin type 1 motif, 1 as a central activator of transforming growth factor beta

Bourd, K., Bonnier, D., Leyme, A., Mari, B. P., Tufféry, P., Samson, M., Ezan, F., Baffet, G., & Théret, N. (2010) · Hepatology · doi:10.1002/hep.24598 · Cited by 94 · see citing works

TGF-β-induced differentiation into myofibroblasts involves specific regulation of two MKL1 isoforms

Scharenberg, M. A., Pippenger, B. E., Sack, R., Zingg, D., Ferralli, J., Schenk, S., Martín, I., & Chiquet‐Ehrismann, R. (2014) · Journal of Cell Science · doi:10.1242/jcs.142075 · Cited by 93 · see citing works

TGFβ stimulated re-epithelialisation is regulated by CTGF and Ras/MEK/ERK signalling

Secker, G. A., Shortt, A. J., Sampson, E. M., Schwarz, Q., Schultz, G. S., & Daniels, J. T. (2007) · Experimental Cell Research · doi:10.1016/j.yexcr.2007.09.001 · Cited by 90 · see citing works

Antibody-targeted myofibroblast apoptosis reduces fibrosis during sustained liver injury

Douglass, A., Wallace, K., Parr, R., Park, J., Durward, E., Broadbent, I. D., Barelle, C. J., Porter, A. J., & Wright, M. C. (2008) · Journal of Hepatology · doi:10.1016/j.jhep.2008.01.032 · Cited by 88 · see citing works

New therapeutics for the prevention and reduction of scarring

Occleston, N. L., O’Kane, S., Goldspink, N., & Ferguson, M. W. J. (2008) · Drug Discovery Today · doi:10.1016/j.drudis.2008.08.009 · Cited by 87 · see citing works

Studies on beta‐aminopropionitrile in patients with scleroderma

Keiser, H. R., & Sjoerdsma, A. (1967) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt196784593 · Cited by 80 · see citing works

Substrate stiffness regulates temporary NF-κB activation via actomyosin contractions

Ishihara, S., Yasuda, M., Harada, I., Mizutani, T., Kawabata, K., & Haga, H. (2013) · Experimental Cell Research · doi:10.1016/j.yexcr.2013.09.018 · Cited by 76 · see citing works

Elucidating the druggable interface of protein−protein interactions using fragment docking and coevolutionary analysis

Bai, F., Morcos, F., Cheng, R. R., Jiang, H., & Onuchic, J. N. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1615932113 · Cited by 76 · see citing works

Constitutive phosphorylation of focal adhesion kinase is involved in the myofibroblast differentiation of scleroderma fibroblasts

Mimura, Y., Ihn, H., Jinnin, M., Asano, Y., Yamane, K., & Tamaki, K. (2005) · Journal of Investigative Dermatology · doi:10.1111/j.0022-202x.2005.23701.x · Cited by 70 · see citing works

The treatment of idiopathic pulmonary fibrosis

Woodcock, H. V., & Maher, T. M. (2014) · F1000Prime Reports · doi:10.12703/p6-16 · Cited by 63 · see citing works

Targeting the PDGF Signaling Pathway in the Treatment of Non-Malignant Diseases

Heldin, C. (2013) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-013-9484-2 · Cited by 61 · see citing works

Inhibition of Transglutaminase 2, a Novel Target for Pulmonary Fibrosis, by Two Small Electrophilic Molecules

Olsen, K. C., Epa, A. P., Kulkarni, A. A., Kottmann, R. M., McCarthy, C. E., Johnson, G. V. W., Thatcher, T. H., Phipps, R. P., & Sime, P. J. (2013) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2013-0092oc · Cited by 58 · see citing works

Role of Rho-Associated Coiled-Coil Forming Kinase Isoforms in Regulation of Stiffness-Induced Myofibroblast Differentiation in Lung Fibrosis

Htwe, S. S., Cha, B. H., Yue, K., Khademhosseini, A., Knox, A. J., & Ghaemmaghami, A. M. (2017) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2016-0306oc · Cited by 54 · see citing works

Simvastatin Ameliorates Matrix Stiffness-Mediated Endothelial Monolayer Disruption

Lampi, M. C., Faber, C. J., Huynh, J., Bordeleau, F., Zanotelli, M. R., & Reinhart‐King, C. A. (2016) · PLoS ONE · doi:10.1371/journal.pone.0147033 · Cited by 48 · see citing works

Transglutaminase inhibitors: a patent review

Keillor, J. W., & Apperley, K. Y.-P. (2015) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.2016.1115836 · Cited by 46 · see citing works

Pirfenidone Initiates a New Era in the Treatment of Idiopathic Pulmonary Fibrosis

Selvaggio, A. S., & Noble, P. W. (2015) · Annual Review of Medicine · doi:10.1146/annurev-med-120214-013614 · Cited by 45 · see citing works

Transglutaminase-2: evolution from pedestrian protein to a promising therapeutic target

Agnihotri, N., & Mehta, K. (2016) · Amino Acids · doi:10.1007/s00726-016-2320-2 · Cited by 44 · see citing works

Basic and Clinical Research Against Advanced Glycation End Products (AGEs): New Compounds to Tackle Cardiovascular Disease and Diabetic Complications

Nenna, A., Spadaccio, C., Lusini, M., Ulianich, L., Chello, M., & Nappi, F. (2016) · Recent Advances in Cardiovascular Drug Discovery (Formerly Recent Patents on Cardiovascular Drug Discovery) · doi:10.2174/1574890110666151104120039 · Cited by 43 · see citing works

Clinical Benefit of INCB7839, a Potent and Selective Inhibitor of ADAM10 and ADAM17, in Combination with Trastuzumab in Metastatic HER2 Positive Breast Cancer Patients.

Friedman, S., Levy, R., Garrett, W. M., Doval, D., Bondarde, S. A., Sahoo, T., Lokanatha, D., Julka, P. K., Shenoy, K., Nagarkar, R. V., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.sabcs-09-5056 · Cited by 40 · see citing works

3-[2-(Aminomethyl)-5-[(pyridin-4-yl)carbamoyl]phenyl] benzoates as soft ROCK inhibitors

Boland, S., Defert, O., Alen, J., Bourin, A., Castermans, K., Kindt, N., Boumans, N., Panitti, L., de Velde, S. V., Stalmans, I., et al. (2013) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2013.09.040 · Cited by 31 · see citing works

CCR 20th Anniversary Commentary: In the Beginning, There Was PS-341

Teicher, B. A., & Anderson, K. C. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-2549 · Cited by 28 · see citing works

Clostridial C3 Toxins Target Monocytes/Macrophages and Modulate Their Functions

Barth, H., Fischer, S., Möglich, A., & Förtsch, C. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00339 · Cited by 27 · see citing works

Targeted delivery of a novel group of site-directed transglutaminase inhibitors to the liver using liposomes: a new approach for the potential treatment of liver fibrosis

Daneshpour, N., Griffin, M., Collighan, R. J., & Perrie, Y. (2010) · Journal of drug targeting · doi:10.3109/1061186x.2010.531731 · Cited by 25 · see citing works

Targeting cancer cells using aptamers: cell-SELEX approach and recent advancements

Barman, J. (2015) · RSC Advances · doi:10.1039/c4ra12407c · Cited by 23 · see citing works

A new role for Rab GTPases during early mitotic stages

Das, S., Hehnly, H., & Doxsey, S. (2014) · Small GTPases · doi:10.4161/sgtp.29565 · Cited by 23 · see citing works

Rho GEFs and GAPs: Emerging integrators of extracellular matrix signaling

Kutys, M. L., & Yamada, K. M. (2015) · Small GTPases · doi:10.4161/21541248.2014.989792 · Cited by 19 · see citing works

DNA Aptamer Raised against Advanced Glycation End Products Prevents Abnormalities in Electroretinograms of Experimental Diabetic Retinopathy

Maeda, S., Matsui, T., Ojima, A., Suematsu, M., Kaseda, K., Higashimoto, Y., Yamakawa, R., & Yamagishi, S. (2015) · Ophthalmic Research · doi:10.1159/000440768 · Cited by 18 · see citing works

Activation of EGFR signaling in CD44 positive cells promotes aggressive behavior and progression of breast cancer.

Karna, P., Cao, Z., Oprea, G. M., Cohen, C., Harris, W. B., Waller, E. K., O'Regan, R. M., Wc, W., & Yang, L. P. H. (2009) · Cancer Research · doi:10.1158/0008-5472.sabcs-5056 · Cited by 1 · see citing works

Therapeutic Targeting of the Tumor Microenvironment

Bejarano, L., Jordão, M. J. C., & Joyce, J. A. (2021) · Cancer Discovery · doi:10.1158/2159-8290.cd-20-1808 · Cited by 1,672 · see citing works

The stiffness of living tissues and its implications for tissue engineering

Guimarães, C. F., Gasperini, L., Marques, A. P., & Reis, R. L. (2020) · Nature Reviews Materials · doi:10.1038/s41578-019-0169-1 · Cited by 1,515 · see citing works

Extracellular matrix and its therapeutic potential for cancer treatment

Huang, J., Zhang, L., Wan, D., Zhou, L., Zheng, S., Lin, S., & Qiao, Y. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00544-0 · Cited by 962 · see citing works

Extracellular matrix-based materials for regenerative medicine

Hussey, G. S., Dziki, J. L., & Badylak, S. F. (2018) · Nature Reviews Materials · doi:10.1038/s41578-018-0023-x · Cited by 844 · see citing works

TGF-β in Hepatic Stellate Cell Activation and Liver Fibrogenesis—Updated 2019

Dewidar, B., Meyer, C., Dooley, S., & Meindl-Beinker, A. N. (2019) · Cells · doi:10.3390/cells8111419 · Cited by 837 · see citing works

Cold and hot tumors: from molecular mechanisms to targeted therapy

Wu, B., Zhang, B., Li, B., Wu, H., & Jiang, M. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01979-x · Cited by 751 · see citing works

Cellular mechanotransduction in health and diseases: from molecular mechanism to therapeutic targets

Di, X., Gao, X., Peng, L., Ai, J., Jin, X., Qi, S., Li, H., Wang, K., & Luo, D. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01501-9 · Cited by 660 · see citing works

Evasion of apoptosis by myofibroblasts: a hallmark of fibrotic diseases

Hinz, B., & Lagares, D. (2019) · Nature Reviews Rheumatology · doi:10.1038/s41584-019-0324-5 · Cited by 616 · see citing works

The extracellular matrix and the immune system: A mutually dependent relationship

Sutherland, T. E., Dyer, D. P., & Allen, J. E. (2023) · Science · doi:10.1126/science.abp8964 · Cited by 519 · see citing works

Cellular and molecular mechanisms of kidney fibrosis

Djudjaj, S., & Boor, P. (2018) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2018.06.002 · Cited by 478 · see citing works

Tumor initiation and early tumorigenesis: molecular mechanisms and interventional targets

Zhang, S., Xiao, X., Yi, Y., Wang, X., Zhu, L., Shen, Y., Lin, D., & Wu, C. H. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01848-7 · Cited by 440 · see citing works

Engineered materials for organoid systems

Kratochvil, M. J., Seymour, A. J., Li, T. L., Pașca, S. P., Kuo, C. J., & Heilshorn, S. C. (2019) · Nature Reviews Materials · doi:10.1038/s41578-019-0129-9 · Cited by 413 · see citing works

Stiffness Sensing by Cells

Janmey, P. A., Fletcher, D. A., & Reinhart‐King, C. A. (2019) · Physiological Reviews · doi:10.1152/physrev.00013.2019 · Cited by 411 · see citing works

Cell Adhesion by Integrins

Bachmann, M., Kukkurainen, S., Hytönen, V. P., & Wehrle‐Haller, B. (2019) · Physiological Reviews · doi:10.1152/physrev.00036.2018 · Cited by 400 · see citing works

The extracellular matrix as hallmark of cancer and metastasis: From biomechanics to therapeutic targets

Sleeboom, J. J. F., van Tienderen, G. S., Schenke‐Layland, K., van der Laan, L. J. W., Khalil, A., & Verstegen, M. M. A. (2024) · Science Translational Medicine · doi:10.1126/scitranslmed.adg3840 · Cited by 391 · see citing works

Simtuzumab Is Ineffective for Patients With Bridging Fibrosis or Compensated Cirrhosis Caused by Nonalcoholic Steatohepatitis

Harrison, S. A., Abdelmalek, M. F., Caldwell, S., Shiffman, M. L., Diehl, A. M., Ghalib, R., Lawitz, E. J., Rockey, D. C., Schall, R. A., Jia, C., et al. (2018) · Gastroenterology · doi:10.1053/j.gastro.2018.07.006 · Cited by 384 · see citing works

Targeting lysyl oxidase (LOX) overcomes chemotherapy resistance in triple negative breast cancer

Saatci, Ö., Kaymak, A., Raza, U., Ersan, P. G., Akbulut, Ö., Banister, C. E., Sikirzhytski, V., Tokat, Ü. M., Aykut, G., Ansari, S. A., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-16199-4 · Cited by 373 · see citing works

Tumor stiffening reversion through collagen crosslinking inhibition improves T cell migration and anti-PD-1 treatment

Nicolás‐Boluda, A., Vaquero, J., Vimeux, L., Guilbert, T., Ghamry-Barrin, S., Kantari‐Mimoun, C., Ponzo, M., Renault, G., Deptuła, P., Pogoda, K., et al. (2021) · eLife · doi:10.7554/elife.58688 · Cited by 371 · see citing works

Reduction of Liver Metastasis Stiffness Improves Response to Bevacizumab in Metastatic Colorectal Cancer

Shen, Y., Wang, X., Lu, J., Salfenmoser, M., Wirsik, N. M., Schleußner, N., Imle, A., Valls, A. F., Radhakrishnan, P., Liang, J., et al. (2020) · Cancer Cell · doi:10.1016/j.ccell.2020.05.005 · Cited by 337 · see citing works

Mechanisms and impact of altered tumour mechanics

Mohammadi, H., & Sahai, E. (2018) · Nature Cell Biology · doi:10.1038/s41556-018-0131-2 · Cited by 336 · see citing works

Targeting the tumor stroma for cancer therapy

Xu, M., Zhang, T., Xia, R., Wei, Y., & Wei, X. (2022) · Molecular Cancer · doi:10.1186/s12943-022-01670-1 · Cited by 322 · see citing works

Mechanoregulation of YAP and TAZ in Cellular Homeostasis and Disease Progression

Cai, X., Wang, K.-C., & Meng, Z. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.673599 · Cited by 311 · see citing works

Tumour-associated macrophages drive stromal cell-dependent collagen crosslinking and stiffening to promote breast cancer aggression

Maller, O., Drain, A. P., Barrett, A. S., Borgquist, S., Ruffell, B., Zakharevich, I., Pham, T. T. M., Gruosso, T., Kuasne, H., Lakins, J. N., et al. (2020) · Nature Materials · doi:10.1038/s41563-020-00849-5 · Cited by 295 · see citing works

Ovarian stiffness increases with age in the mammalian ovary and depends on collagen and hyaluronan matrices

Amargant, F., Manuel, S. L., Tu, Q., Parkes, W. S., Rivas, F., Zhou, L. T., Rowley, J. E., Villanueva, C. E., Hornick, J. E., Shekhawat, G. S., et al. (2020) · Aging Cell · doi:10.1111/acel.13259 · Cited by 280 · see citing works

Multifaceted Design and Emerging Applications of Tissue Adhesives

Ma, Z., Bao, G., & Li, J. (2021) · Advanced Materials · doi:10.1002/adma.202007663 · Cited by 271 · see citing works

Myofibroblasts: Function, Formation, and Scope of Molecular Therapies for Skin Fibrosis

Tai, Y., Woods, E. L., Dally, J., Kong, D., Steadman, R., Moseley, R., & Midgley, A. C. (2021) · Biomolecules · doi:10.3390/biom11081095 · Cited by 244 · see citing works

Enhancing CRISPR/Cas gene editing through modulating cellular mechanical properties for cancer therapy

Zhang, D., Wang, G., Yu, X., Wei, T., Farbiak, L., Johnson, L. T., Taylor, A. M., Xu, J., Hong, Y., Zhu, H., et al. (2022) · Nature Nanotechnology · doi:10.1038/s41565-022-01122-3 · Cited by 243 · see citing works

Mechanical communication in fibrosis progression

Long, Y., Niu, Y., Liang, K., & Du, Y. (2022) · Trends in Cell Biology · doi:10.1016/j.tcb.2021.10.002 · Cited by 233 · see citing works

The Role of Myofibroblasts in Physiological and Pathological Tissue Repair

Schuster, R., Younesi, F., Ezzo, M., & Hinz, B. (2023) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a041231 · Cited by 232 · see citing works

The Extracellular Matrix: Its Composition, Function, Remodeling, and Role in Tumorigenesis

Dzobo, K., & Dandara, C. (2023) · Biomimetics · doi:10.3390/biomimetics8020146 · Cited by 209 · see citing works

Simtuzumab for primary sclerosing cholangitis: phase 2 study results with insights on the natural history of the disease

Muir, A. J., Levy, C., Janssen, H. L. A., Montano‐Loza, A. J., Shiffman, M. L., Caldwell, S., Luketic, V., Ding, D., Jia, C., McColgan, B. J., et al. (2019) · Hepatology · doi:10.1002/hep.30237 · Cited by 195 · see citing works

Mechanical regulation of myofibroblast phenoconversion and collagen contraction

Hinz, B., McCulloch, C. A., & Coelho, N. M. (2019) · Experimental Cell Research · doi:10.1016/j.yexcr.2019.03.027 · Cited by 182 · see citing works

The inflammatory speech of fibroblasts

Schuster, R., Rockel, J. S., Kapoor, M., & Hinz, B. (2021) · Immunological Reviews · doi:10.1111/imr.12971 · Cited by 174 · see citing works

Harnessing the tumor microenvironment: targeted cancer therapies through modulation of epithelial-mesenchymal transition

Glaviano, A., Lau, H., Carter, L. M., Lee, E. H. C., Lam, H. Y., Okina, E., Tan, D. J. J., Tan, W., Ang, H. L., Carbone, D., et al. (2025) · Journal of Hematology & Oncology · doi:10.1186/s13045-024-01634-6 · Cited by 162 · see citing works

Mechanical Aspects of Angiogenesis

Kretschmer, M., Rüdiger, D., & Zahler, S. (2021) · Cancers · doi:10.3390/cancers13194987 · Cited by 151 · see citing works

Extracellular matrix dynamics in tumor immunoregulation: from tumor microenvironment to immunotherapy

Hu, Q., Zhu, Y., Mei, J., Liu, Y. L., & Zhou, G. (2025) · Journal of Hematology & Oncology · doi:10.1186/s13045-025-01717-y · Cited by 151 · see citing works

Extracellular Matrix Remodeling in Vascular Disease: Defining Its Regulators and Pathological Influence

Lin, P. K., & Davis, G. E. (2023) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.123.318237 · Cited by 145 · see citing works

Targeting Mechanics-Induced Fibroblast Activation through CD44-RhoA-YAP Pathway Ameliorates Crystalline Silica-Induced Silicosis

Li, S., Li, C. R., Zhang, Y., He, X., Chen, X., Zeng, X., Liu, F., Chen, Y., & Chen, J. (2019) · Theranostics · doi:10.7150/thno.35665 · Cited by 143 · see citing works

Two-Dimensional MXene-Originated In Situ Nanosonosensitizer Generation for Augmented and Synergistic Sonodynamic Tumor Nanotherapy

Zhang, M., Yang, D., Dong, C., Huang, H., Feng, G., Chen, Q., Zheng, Y., Tang, H., Chen, Y., & Jing, X. (2022) · ACS Nano · doi:10.1021/acsnano.2c04630 · Cited by 143 · see citing works

Mechano-therapeutics: Targeting Mechanical Signaling in Fibrosis and Tumor Stroma

Tschumperlin, D. J., & Lagares, D. (2020) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2020.107575 · Cited by 142 · see citing works

Methods of Delivering Mechanical Stimuli to Organ-on-a-Chip

Kaarj, K., & Yoon, J. (2019) · Micromachines · doi:10.3390/mi10100700 · Cited by 140 · see citing works

Regulation of cellular senescence by extracellular matrix during chronic fibrotic diseases

Blokland, K. E. C., Pouwels, S. D., Schuliga, M. J., Knight, D. A., & Burgess, J. K. (2020) · Clinical Science · doi:10.1042/cs20190893 · Cited by 129 · see citing works

Biophysics in tumor growth and progression: from single mechano-sensitive molecules to mechanomedicine

Xin, Y., Li, K., Huang, M. L., Liang, C., Siemann, D. W., Wu, L., Tan, Y., & Tang, X. (2023) · Oncogene · doi:10.1038/s41388-023-02844-x · Cited by 125 · see citing works

The Extracellular Matrix in Pancreatic Cancer: Description of a Complex Network and Promising Therapeutic Options

Ferrara, B., Pignatelli, C., Cossutta, M., Citro, A., Courty, J., & Piemonti, L. (2021) · Cancers · doi:10.3390/cancers13174442 · Cited by 121 · see citing works

Towards extracellular matrix normalization for improved treatment of solid tumors

Abyaneh, H. S., Regenold, M., McKee, T. D., Allen, C. J., & Gauthier, M. A. (2020) · Theranostics · doi:10.7150/thno.39995 · Cited by 117 · see citing works

Signaling Mechanisms of Myofibroblastic Activation: Outside-in and Inside-Out

Zent, J. M., & Guo, L. (2018) · Cellular Physiology and Biochemistry · doi:10.1159/000493217 · Cited by 115 · see citing works

Nuclear deformation guides chromatin reorganization in cardiac development and disease

Seelbinder, B., Ghosh, S., Schneider, S. E., Scott, A. K., Berman, A. G., Goergen, C. J., Margulies, K. B., Bedi, K. C., Casas, E., Swearingen, A. R., et al. (2021) · Nature Biomedical Engineering · doi:10.1038/s41551-021-00823-9 · Cited by 115 · see citing works

Unravelling cell migration: defining movement from the cell surface

Merino-Casallo, F., Gómez‐Benito, M. J., Hervás-Raluy, S., & García‐Aznar, J. M. (2022) · Cell Adhesion & Migration · doi:10.1080/19336918.2022.2055520 · Cited by 114 · see citing works

Ten Years of Extracellular Matrix Proteomics: Accomplishments, Challenges, and Future Perspectives

Naba, A. (2023) · Molecular & Cellular Proteomics · doi:10.1016/j.mcpro.2023.100528 · Cited by 112 · see citing works

Evidence and therapeutic implications of biomechanically regulated immunosurveillance in cancer and other diseases

Mittelheisser, V., Gensbittel, V., Bonati, L., Li, W., Tang, L., & Goetz, J. G. (2024) · Nature Nanotechnology · doi:10.1038/s41565-023-01535-8 · Cited by 109 · see citing works

Matrix Stiffness Triggers Lipid Metabolic Cross-talk between Tumor and Stromal Cells to Mediate Bevacizumab Resistance in Colorectal Cancer Liver Metastases

Zheng, Y., Zhou, R., Cai, J., Yang, N., Wen, Z., Zhang, Z., Sun, H., Huang, G., Guan, Y., Huang, N., et al. (2023) · Cancer Research · doi:10.1158/0008-5472.can-23-0025 · Cited by 105 · see citing works

From Design to Clinic: Engineered Nanobiomaterials for Immune Normalization Therapy of Cancer

Saeed, M., Chen, F., Ye, J., Shi, Y., Lammers, T., Geest, B. G. D., Xu, Z. P., & Yu, H. (2021) · Advanced Materials · doi:10.1002/adma.202008094 · Cited by 101 · see citing works

Extracellular matrix requirements for gastrointestinal organoid cultures

Rezakhani, S., Gjorevski, N., & Lutolf, M. P. (2021) · Biomaterials · doi:10.1016/j.biomaterials.2021.121020 · Cited by 100 · see citing works

TAGLN mediated stiffness-regulated ovarian cancer progression via RhoA/ROCK pathway

Xiao, W., Lou, H., Zhou, D., Jia, Y., Li, H., Huang, Q., Ma, J., Yang, Z., Sun, C., Meng, Y., et al. (2021) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-021-02091-6 · Cited by 100 · see citing works

Understanding Multicellularity: The Functional Organization of the Intercellular Space

Bich, L., Pradeu, T., & Moreau, J. (2019) · Frontiers in Physiology · doi:10.3389/fphys.2019.01170 · Cited by 99 · see citing works

The biophysics and mechanics of blood from a materials perspective

Qiu, Y., Myers, D. R., & Lam, W. A. (2019) · Nature Reviews Materials · doi:10.1038/s41578-019-0099-y · Cited by 96 · see citing works

The Matrisome during Aging and Longevity: A Systems-Level Approach toward Defining Matreotypes Promoting Healthy Aging

Ewald, C. Y. (2019) · Gerontology · doi:10.1159/000504295 · Cited by 96 · see citing works

Circular RNAs in the tumour microenvironment

Ma, Z., Shuai, Y., Gao, X., Wen, X., & Ji, J. (2020) · Molecular Cancer · doi:10.1186/s12943-019-1113-0 · Cited by 96 · see citing works

Decellularized tissues as platforms for in vitro modeling of healthy and diseased tissues

McCrary, M. W., Bousalis, D., Mobini, S., Song, Y. H., & Schmidt, C. E. (2020) · Acta Biomaterialia · doi:10.1016/j.actbio.2020.05.031 · Cited by 96 · see citing works

Incorporating mechanical strain in organs-on-a-chip: Lung and skin

Guenat, O. T., & Francois Berthiaume, B. (2018) · Biomicrofluidics · doi:10.1063/1.5024895 · Cited by 95 · see citing works

Tumor Extracellular Matrix Remodeling: New Perspectives as a Circulating Tool in the Diagnosis and Prognosis of Solid Tumors

Giussani, M., Triulzi, T., Sozzi, G., & Tagliabue, E. (2019) · Cells · doi:10.3390/cells8020081 · Cited by 95 · see citing works

Photo-tunable hydrogels reveal cellular sensing of rapid rigidity changes through the accumulation of mechanical signaling molecules

Yang, J., Wang, P., Zhang, Y., Zhang, M., Sun, Q., Chen, H., Dong, L., Chu, Z., Xue, B., Hoff, W. D., et al. (2024) · Cell stem cell · doi:10.1016/j.stem.2024.09.016 · Cited by 95 · see citing works

Optimized lipid nanoparticles (LNPs) for organ-selective nucleic acids delivery in vivo

Zhang, T., Yin, H., Li, Y., Yang, H., Ge, K., Zhang, J., Yuan, Q., Dai, X., Naeem, A., Weng, Y., et al. (2024) · iScience · doi:10.1016/j.isci.2024.109804 · Cited by 94 · see citing works

Mechanical checkpoint regulates monocyte differentiation in fibrotic niches

Vining, K. H., Marneth, A. E., Adu‐Berchie, K., Grolman, J. M., Tringides, C. M., Liu, Y., Wong, W. J., Pozdnyakova, O., Severgnini, M., Stafford, A. G., et al. (2022) · Nature Materials · doi:10.1038/s41563-022-01293-3 · Cited by 93 · see citing works

Charting the unexplored extracellular matrix in cancer

Filipe, E. C., Chitty, J. L., & Cox, T. R. (2018) · International Journal of Experimental Pathology · doi:10.1111/iep.12269 · Cited by 91 · see citing works

When things go wrong: exploring possible mechanisms driving the progressive fibrosis phenotype in interstitial lung diseases

Selman, M., & Pardo, A. (2021) · European Respiratory Journal · doi:10.1183/13993003.04507-2020 · Cited by 91 · see citing works

Engineered Biomaterial Platforms to Study Fibrosis

Davidson, M. D., Burdick, J. A., & Wells, R. G. (2020) · Advanced Healthcare Materials · doi:10.1002/adhm.201901682 · Cited by 90 · see citing works

The aged extracellular matrix and the profibrotic role of senescence-associated secretory phenotype

Mebratu, Y. A., Soni, S., Rosas, L., Rojas, M. M., Horowitz, J. C., & Nho, R. S. (2023) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00124.2023 · Cited by 89 · see citing works

Extracellular matrix stiffness determines DNA repair efficiency and cellular sensitivity to genotoxic agents

Deng, M., Lin, J., Nowsheen, S., Liu, T., Zhao, Y., Villalta, P. W., Sicard, D., Tschumperlin, D. J., Lee, S., Kim, J.-J., et al. (2020) · Science Advances · doi:10.1126/sciadv.abb2630 · Cited by 88 · see citing works

Extracellular Matrix Stiffness: Mechanotransduction and Mechanobiological Response-Driven Strategies for Biomedical Applications Targeting Fibroblast Inflammation

Tiskratok, W., Chuinsiri, N., Limraksasin, P., Kyawsoewin, M., & Jitprasertwong, P. (2025) · Polymers · doi:10.3390/polym17060822 · Cited by 88 · see citing works

Targeting of pancreatic cancer cells and stromal cells using engineered oncolytic Salmonella typhimurium

Tan, W., Duong, M. T.-Q., Zuo, C., Qin, Y., Zhang, Y., Guo, Y., Hong, Y., Zheng, J. H., & Min, J. (2021) · Molecular Therapy · doi:10.1016/j.ymthe.2021.08.023 · Cited by 87 · see citing works

Matrix stiffness enhances cancer-macrophage interactions and M2-like macrophage accumulation in the breast tumor microenvironment

Taufalele, P., Wang, W., Simmons, A. J., Southard-Smith, A. N., Chen, B., Greenlee, J. D., King, M. R., Lau, K. S., Hassane, D. C., Bordeleau, F., et al. (2022) · Acta Biomaterialia · doi:10.1016/j.actbio.2022.04.031 · Cited by 87 · see citing works

Collagen crosslinking: effect on structure, mechanics and fibrosis progression

Kong, W., Lyu, C., Liao, H., & Du, Y. (2021) · Biomedical Materials · doi:10.1088/1748-605x/ac2b79 · Cited by 85 · see citing works

Niche stiffness sustains cancer stemness via TAZ and NANOG phase separation

Liu, X., Ye, Y., Zhu, L., Xiao, X., Zhou, B., Gu, Y., Si, H., Liang, H., Liu, M., Li, J., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-35856-y · Cited by 85 · see citing works

Mechanical signatures in cancer metastasis

Agrawal, A., Javanmardi, Y., Watson, S. A., Serwinski, B., Djordjevic, B., Li, W., Aref, A. R., Jenkins, R. W., & Moeendarbary, E. (2025) · npj Biological Physics and Mechanics. · doi:10.1038/s44341-024-00007-x · Cited by 85 · see citing works

The Complex Tumor Microenvironment in Ovarian Cancer: Therapeutic Challenges and Opportunities

Garlisi, B., Lauks, S., Aitken, C., Ogilvie, L. M., Lockington, C., Petrik, D., Eichhorn, J. S., & Petrik, J. (2024) · Current Oncology · doi:10.3390/curroncol31070283 · Cited by 83 · see citing works

RNA delivery biomaterials for the treatment of genetic and rare diseases

Zhao, W., Hou, X., Vick, O. G., & Dong, Y. (2019) · Biomaterials · doi:10.1016/j.biomaterials.2019.119291 · Cited by 82 · see citing works

Cell matrix adhesion in cell migration

Conway, J. R. W., & Jacquemet, G. (2019) · Essays in Biochemistry · doi:10.1042/ebc20190012 · Cited by 82 · see citing works

Hyaluronidase: structure, mechanism of action, diseases and therapeutic targets

Lu, J., Zhao, Z., Pan, L., Wu, H. C., Wang, S., Tong, X., & Wu, S. (2025) · Molecular Biomedicine · doi:10.1186/s43556-025-00299-y · Cited by 82 · see citing works

Development of a Novel 3D Tumor-tissue Invasion Model for High-throughput, High-content Phenotypic Drug Screening

Puls, T. J., Tan, X., Husain, M., Whittington, C. F., Fishel, M. L., & Voytik‐Harbin, S. L. (2018) · Scientific Reports · doi:10.1038/s41598-018-31138-6 · Cited by 81 · see citing works

Passive stiffness of fibrotic skeletal muscle in mdx mice relates to collagen architecture

Brashear, S. E., Wohlgemuth, R. P., Gonzalez, G., & Smith, L. (2020) · The Journal of Physiology · doi:10.1113/jp280656 · Cited by 78 · see citing works

Vascular stiffening and endothelial dysfunction in atherosclerosis

Hooglugt, A., Klatt, O. C., & Huveneers, S. (2022) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000852 · Cited by 77 · see citing works

Tunable hydrogels for controlling phenotypic cancer cell states to model breast cancer dormancy and reactivation

Pradhan, S., & Slater, J. H. (2019) · Biomaterials · doi:10.1016/j.biomaterials.2019.04.022 · Cited by 76 · see citing works

The glycocalyx core protein Glypican 1 protects vessel wall endothelial cells from stiffness-mediated dysfunction and disease

Mahmoud, M. M., Mayer, M., Cancel, L. M., Bartosch, A. M. W., Mathews, R., & Tarbell, J. M. (2020) · Cardiovascular Research · doi:10.1093/cvr/cvaa201 · Cited by 76 · see citing works

Tissue Rheology as a Possible Complementary Procedure to Advance Histological Diagnosis of Colon Cancer

Deptuła, P., Łysik, D., Pogoda, K., Cieśluk, M., Namiot, A., Mystkowska, J., Król, G., Głuszek, S., Janmey, P. A., & Bucki, R. (2020) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.0c00975 · Cited by 74 · see citing works

Targeting transforming growth factor-β signaling for enhanced cancer chemotherapy

Chen, J., Ding, Z., Li, S., Liu, S., Xiao, C., Li, Z., Zhang, B., Chen, X., & Yang, X. (2020) · Theranostics · doi:10.7150/thno.51383 · Cited by 73 · see citing works

Targeting extracellular matrix stiffness for cancer therapy

Feng, X., Cao, F., Wu, X., Xie, W., Wang, P., & Jiang, H. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1467602 · Cited by 73 · see citing works

Matrix Mechanics as Regulatory Factors and Therapeutic Targets in Hepatic Fibrosis

Chen, G., Xia, B., Fu, Q., Xiang, H., Wang, F., Chen, Z., & Lv, Y. (2019) · International Journal of Biological Sciences · doi:10.7150/ijbs.37500 · Cited by 72 · see citing works

Injury- and inflammation-driven skin fibrosis: The paradigm of epidermolysis bullosa

Nyström, A., & Bruckner‐Tuderman, L. (2018) · Matrix Biology · doi:10.1016/j.matbio.2018.01.016 · Cited by 71 · see citing works

Fluctuation-Based Super-Resolution Traction Force Microscopy

Stubb, A., Laine, R. F., Miihkinen, M., Hamidi, H., Guzmán, C., Henriques, R., Jacquemet, G., & Ivaska, J. (2020) · Nano Letters · doi:10.1021/acs.nanolett.9b04083 · Cited by 70 · see citing works

Specific ECM degradation potentiates the antitumor activity of CAR-T cells in solid tumors

Zheng, R., Shen, K., Liang, S., Lyu, Y., Zhang, S., Dong, H., Li, Y., Han, Y., Zhao, X., Zhang, Y., et al. (2024) · Cellular and Molecular Immunology · doi:10.1038/s41423-024-01228-9 · Cited by 69 · see citing works

Multiscale Mechanobiology in Brain Physiology and Diseases

Procès, A., Luciano, M., Kalukula, Y., Ris, L., & Gabriele, S. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.823857 · Cited by 68 · see citing works

Advanced glycation end-products as mediators of the aberrant crosslinking of extracellular matrix in scarred liver tissue

Lyu, C., Kong, W., Liu, Z., Wang, S., Zhao, P., Liang, K., Niu, Y., Yang, W., Xiang, C., Hu, X., et al. (2023) · Nature Biomedical Engineering · doi:10.1038/s41551-023-01019-z · Cited by 67 · see citing works

High-frequency microrheology in 3D reveals mismatch between cytoskeletal and extracellular matrix mechanics

Staunton, J. R., So, W. Y., Paul, C. D., & Tanner, K. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1814271116 · Cited by 67 · see citing works

Matrix stiffness induces Drp1-mediated mitochondrial fission through Piezo1 mechanotransduction in human intervertebral disc degeneration

Ke, W., Wang, B., Liao, Z., Song, Y., Li, G., Ma, L., Wang, K., Li, S., Hua, W., & Cao, Y. (2023) · Journal of Translational Medicine · doi:10.1186/s12967-023-04590-w · Cited by 66 · see citing works

Silencing COX-2 blocks PDK1/TRAF4-induced AKT activation to inhibit fibrogenesis during skeletal muscle atrophy

Chen, H., Qian, Z., Zhang, S., Tang, J. X., Fang, L., Jiang, F., Ge, D., Chang, J., Cao, J., Yang, L., et al. (2020) · Redox Biology · doi:10.1016/j.redox.2020.101774 · Cited by 65 · see citing works

Chronic lung diseases: entangled in extracellular matrix

Burgess, J. K., & Harmsen, M. C. (2022) · European Respiratory Review · doi:10.1183/16000617.0202-2021 · Cited by 65 · see citing works

Progress in the mechanical modulation of cell functions in tissue engineering

Dey, K., Roca, E., Ramorino, G., & Sartore, L. (2020) · Biomaterials Science · doi:10.1039/d0bm01255f · Cited by 64 · see citing works

New insights into the Hippo/YAP pathway in idiopathic pulmonary fibrosis

Sun, M., Sun, Y., Feng, Z., Kang, X., Yang, W., Wang, Y., & Luo, Y. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2021.105635 · Cited by 64 · see citing works

Matrix Stiffness and Colorectal Cancer

Liu, C., Pei, H., & Tan, F. (2020) · OncoTargets and Therapy · doi:10.2147/ott.s231010 · Cited by 63 · see citing works

Matrix stiffness-driven cancer progression and the targeted therapeutic strategy

Liang, R., & Song, G. (2023) · Mechanobiology in Medicine · doi:10.1016/j.mbm.2023.100013 · Cited by 44 · see citing works

ECM-Targeted and cell-based therapies in musculoskeletal and aging-related disorders: A review

Ahn, K., & Park, H. (2026) · Technology and Health Care · doi:10.1177/09287329251414507 · Cited by 3 · see citing works

The extracellular matrix and transforming growth factor-β1: Tale of a strained relationship

Hinz, B. (2015) · Matrix Biology · doi:10.1016/j.matbio.2015.05.006 · Cited by 618 · see citing works

Extracellular Matrix Stiffness in Lung Health and Disease

Guo, T., He, C., Venado, A. E., & Zhou, Y. (2022) · Comprehensive physiology · doi:10.1002/j.2040-4603.2022.tb00222.x · Cited by 48 · see citing works

Extracellular Matrix Stiffness Exists in a Feedback Loop that Drives Tumor Progression.

Simi, A., Pang, M., & Nelson, C. (2018) · Advances in Experimental Medicine and Biology · doi:10.1007/978-3-319-95294-9_4 · Cited by 33 · see citing works